Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma
August 16, 2023 07:00 ET
|
AEON Biopharma
The 7,380,394 AEON shares reflected in the Form 4 filed on August 14th were transferred to limited partners of Strathspey Crown Strathspey Crown did not sell any AEON shares to the public as part...
An Old Dog with a New Trick… Ellodi’s APT-1011 Promises EoE Patients a Convenient and Potent Treatment Alternative
August 15, 2023 15:40 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Since launching in May 2022, Sanofi/Regeneron’s Dupixent has been well received by gastroenterologists and allergists as an advancement for...
Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on New ‘Dendranib’ Nanomedicine Candidate at the 16th International Society of Neuroimmunology Congress (ISNI)
August 15, 2023 08:30 ET
|
Ashvattha Therapeutics
Data will showcase anti-inflammatory and immunomodulatory effects of ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, in a mouse model of multiple sclerosis REDWOOD CITY, Calif.,...
Nextech Launches New Med Spa Software that Drives Facility Growth in a Rapidly Evolving Industry
August 15, 2023 08:00 ET
|
Nextech Systems, Inc.
TAMPA, Fla., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Nextech, a complete healthcare technology solution for specialty providers, announced today the debut of Nextech Med Spa, the industry's first...
Adverum Biotechnologies to Participate in the H.C. Wainwright 3rd Annual Ophthalmology Virtual Conference
August 14, 2023 08:00 ET
|
Adverum Biotechnologies, Inc.
REDWOOD CITY, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for...
Tersigni Vision Announces Advanced, Personalized LASIK Procedures for Improved Vision Correction
August 11, 2023 17:47 ET
|
Tersigni Vision
Lake Oswego, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Lake Oswego, Oregon - Today, Tersigni Vision, a trailblazer in the field of eye-care, unveils the latest advancements in Laser-Assisted In-Situ...
Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements
August 10, 2023 16:05 ET
|
Tarsus Pharmaceuticals, Inc
XDEMVY™ (lotilaner ophthalmic solution) 0.25% received FDA approval for the treatment for Demodex blepharitis On track to have XDEMVY and sales force in market by the end of August 2023 Completed...
Iridex Reports Second Quarter 2023 Financial Results
August 10, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
What’s on Your Must-Read List? If You Work in Pharma, Add Spherix Global Insights’ Generalized Myasthenia Gravis Patient Chart Audit to that List
August 10, 2023 15:15 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 10, 2023 (GLOBE NEWSWIRE) -- In one of the largest patient-focused studies ever conducted in gMG, Spherix’s RealWorld Dynamix™: Treatment Patterns in generalized Myasthenia...
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
August 10, 2023 08:00 ET
|
MeiraGTx
Phase 3 LUMEOS clinical trial of botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) enrollment target has now been surpassedAnnounced...